Endocrinology

Articles

• 2018. Weatherall J et al. – When insulin degludec enhances quality of life in patients with type 2 diabetes: A qualitative investigation
• 2018. Jendle J et al. – A utility valuation study assessing the impact of postprandial glucose control on quality of life of individuals with type 1 or type 2 diabetes
• 2017. Balkau B et al. – The use of saxagliptin in people with type 2 diabetes in France: The DIAPAZON epidemiological study
• 2017. Peters ML et al. – The current total economic burden of diabetes mellitus in the Netherlands
• 2016. Boxall N et al. – Evaluation of exposure to pioglitazone and risk of prostate cancer: A nested case–control study
• 2016. Grimaldi A. et al – Breaking barriers to effective type 2 diabetes management: Findings from the use of the OPTIMA© Questionnaire in clinical practice
• 2016. Giustina A et al. – SAGIT©: Clinician-reported outcome tool for managing acromegaly in clinical practice. Development and results from a pilot study
• 2015. Roborel de Climens A et al. – Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy
• 2012. Gilet H et al. – Demonstrating the burden of hypoglycemia on patients’ quality of life in diabetes clinical trials: Measurement considerations for hypoglycemia
• 2011. Dias-Barbosa C et al. – Considering the patient perspective for assessing the outcomes of diabetes lifestyle modification programmes
• 2011. Gilet H et al. – In response to McKenna and John Brodersen’s letter to editor. Application of the disease-specific quality of life assessment of growth hormone deficiency in adults (QOL-AGHDA) questionnaire in a general population: Results from a French panel study
• 2010. Yi Y et al – Economic models in type 2 diabetes
• 2009. Arbuckle RA et al. – Psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) – A measure of symptom distress
• 2009. Ringborg A et al. – Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: Results from the International Diabetes Management Practices Study (IDMPS)
• 2009. Jansen JP et al. – Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK
• 2008. Viala-Danten M et al. – Evaluation of the reliability and validity of the Medical Outcomes Study sleep scale in patients with painful diabetic peripheral neuropathy during an international clinical trial

Posters & Presentations

• 2017. ISPOR European Congress – Adherence issues in diabetes treatment: How can acceptance measurement help understanding patients’ concerns and working on solutions?
• 2017. American Diabetes Association Scientific Sessions – Qualitative assessment of the impact of insulin degludec on quality of life in patients with type 2 diabetes
• 2017. Congrès Annuel de la Société Francophone du Diabète (SFD) – Résultats de l’étude DIAPAZON portant sur l’utilisation de la saxagliptine en France
• 2016. ISPOR European Congress – Improvements in Health-Related Quality of Life Associated with Increased Control of Postprandial Glucose Levels in Diabetes
• 2016. EASD Annual Meeting – Depressive Symptoms in People with Diabetes: Results from the International Diabetes Management Practices Survey
• 2016. ISPOR Annual International Meeting – Patient-Reported Outcomes (PRO) Claims in Acromegaly: A Review of the Labels of Products Approved by the FDA and the EMA
• 2016. SFD Annual Congress – Supprimer les Barrières à une Gestion du Diabète de Type 2 : Résultats de l’Utilisation de l’Outil OPTIMA en Pratique Courante
• 2016. SFD Annual Congress – Autogestion du Diabète de Type 1 au Moyen Orient et en Afrique du Nord: Résultats de l’Etude IDMPS
• 2015. IDF World Diabetes Congress – Glycemic control and hypoglycemia frequency in adults with diabetes: Results from the IDMPS study
• 2015. SFD Annual Congress – Résultats de l’étude DIAPAZON portant sur l’utilisation de la saxagliptine en France : Données de suivi à 12 mois (DIAPAZON: Saxagliptin Drug Utilization French Study – 12-month follow-up results)
• 2014. ISPOR European Congress – SAGIT©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice
• 2014. Endocrine Society Annual Meeting – SAGIT©: A novel comprehensive clinical practice tool for managing acromegaly.
• 2013. ISPOR European Congress – Preliminary Testing of the SAGIT© Tool: A Tool to Help Endocrinologists in their Management of Patients with Acromegaly in Clinical Practice
• 2013. ISPOR European Congress – Do EMA and FDA Have Different Opinions/Requirements in Terms of Pediatric Studies for Sitagliptin (Alone or in Combination)?
• 2013. ISPOR Annual International Meeting – Patient-Reported Outcomes (PROs) in Anti-Diabetic Product Approvals in Europe and in the USA.
• 2012. ISPOR European Congress – Characteristics of Long-Acting Somatostatin (SSA) Use in Acromegaly in the Netherlands
• 2012. ISPOR Annual International Meeting – Instruments Measuring Treatment Adherence and Compliance in Diabetes Mellitus: A Literature Review
• 2010. ISOQOL Annual Conference – Is it Necessary to Adapt the UK English Original of the Diabetes Treatment Satisfaction Questionnaire (DTSQs) before Use in Other Countries?
• 2010. ISOQOL Annual Conference – Content Validity of Utility Assessments in Type 2 Diabetes and Alzheimer’s Disease.
• 2010. ISPOR Annual International Meeting – Using the Pediatric Quality of LifeTM (PEDSQLTM) Diabetes Module to Study Similarities and Differences in Target Languages
• 2009. ISPOR European Congress – Linguistic Validation, Including Cultural Adaptation, of an Updated ADKNOWL, Diabetes Know ledge Questionnaire, for International Use
• 2009. ISPOR European Congress – Critical Review of Economic Models in Type 2 Diabetes
• 2008. ISPOR European Congress – French Normative Reference Data for the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QOL-AGHDA) Questionnaire
• 2008. ISPOR European Congress – Conceptual Development of a Patient Self-Assessment Tool to Improve Patient- Clinician Communication on the Daily Management of Type 2 Diabetes.
• 2008. ISPOR Asia-Pacific Conference – Transferability of Patient-Reported Outcomes in Diabetes: Cultural Differences in Japan
• 2006. ISPOR European Congress – Scoring and Psychometric Validation of a scale for Diabetic Patient Profiling Based on Patient Attitude Towards Insulin
• 2005. ISPOR European Congress – Development of a Scale for Diabetic Patient Profiling Based on Patient Attitude Towards Insulin
• 1997. ISPOR Annual International Meeting – Psychological Adjustment Among NIDDM Patients in Transition from Oral Agents to Insulin Therapy

vero.